ArticlePLoS pathogens2020

4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.

Daniele Veggi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.